Markus Joerger - Dissemin

Language
Login

All papers authored by Markus Joerger

This paper was not found in any repository, but could be made available legally by the author.

2022 Fiamma Berner, David Bomze

ORCID

, Christa Lichtensteiger

ORCID

, Vincent Walter, Rebekka Niederer, Oh Ali, Omar Hasan Ali

ORCID

, Nina Wyss, Jens Bauer

ORCID

, Lena Katharina Freudenmann

ORCID

ORCID

, Eva-Maria Wolfschmitt, Sebastian Haen, Thorben Gross

ORCID

, Marie-Therese Abdou and 20 other authors

Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade

Upload

This paper is made freely available by the publisher.

2019 Andreas Schneeweiss, Dagmar Hess, Markus Joerger

ORCID

ORCID

, Stacy Moulder, Apostolia M. Tsimberidou, Cynthia Ma, Sara A. Hurvitz, Christine Rentzsch, Marion Rudolph, Silke Thiele, Oliver Boix

ORCID

, Gary Wilkinson

ORCID

, Eleni Lagkadinou, Matthias Ocker

ORCID

Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer—Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Ivo Überall, Mariam Gachechiladze

ORCID

, Markus Joerger

ORCID

, Josef Anděl, Petra Smičková, Vítězslav Kolek, Ivona Grygárková, Josef Škarda

Tumor autophagy is associated with survival outcomes in patients with resected non-small cell lung cancer

Upload

This paper is made freely available by the publisher.

Odharnaith O’Brien, Mark Wright, Cathal O’Brien, Orla Geoghegan, Niamh Leonard, Siobhan Nicholson, Sinéad Cuffe, Aurelie Fabre

ORCID

, Wolfram Jochum, Markus Joerger

ORCID

, Steven Gray, Stephen Finn

Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2018 Andreas Wicki

ORCID

, Nicholas Brown, Alexandros Xyrafas, Vincent Bize, Hanne Hawle, Simona Berardi, Nataša Cmiljanović, Vladimir Cmiljanović, Michael Stumm, Saša Dimitrijević, Richard Herrmann, Vincent Prêtre, Reto Ritschard, Alexandar Tzankov, Viviane Hess and 8 other authors

First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)

Upload

Distributing this paper is prohibited by the publisher

2017 Andrea Henrich, Markus Joerger

ORCID

, Stefanie Kraff, Ulrich Jaehde, Wilhelm Huisinga, Charlotte Kloft, Zinnia Patricia Parra-Guillen

Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia

Upload

This paper was not found in any repository, but could be made available legally by the author.

2016 P. Neumair

ORCID

, L. Joos

ORCID

, R. Warschkow, A. Dutly, S. Ess, F. Hitz, M. Früh, M. Brutsche, F. Baty, S. Krähenbühl, T. Cerny, M. Joerger

ORCID

Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study

Upload

Missing publications? Search for publications with a matching author name.